SCHEMBL22908036

SCHEMBL22908036

c1ccc(-c2ccc(-c3c4ccccc4c(-c4cccc5c4oc4ccc6oc7ccccc7c6c45)c4ccccc34)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.43
▸ CDC14B O60729 2/20 0.38
▸ CDC14A Q9UNH5 2/20 0.38
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ PLA2G2A P14555 4/20 0.37
▸ PLA2G4A P47712 4/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ CSF1R P07333 1/20 0.35
▸ PDGFRB P09619 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KIT P10721 1/20 0.35
▸ FLT3 P36888 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22908071 0.97 ALOX5 (0.41) ALOX5CDC14BCDC14ACA1CA2
SCHEMBL24662710 0.92 ALOX5 (0.41) ALOX5CDC14BCDC14ACA1CA2
SCHEMBL23427125 0.91 ALOX5 (0.41) ALOX5CDC14BCDC14ACA1CA2
SCHEMBL23427591 0.91 ALOX5 (0.41) ALOX5CDC14BCDC14ACA1CA2
SCHEMBL19076412 0.90 ALOX5 (0.43) ALOX5CDC14BCDC14ACA1CA2
SCHEMBL22907989 0.90 CDC14B (0.41) ALOX5CDC14BCDC14ACA1CA2
SCHEMBL23428219 0.90 ALOX5 (0.42) ALOX5CDC14BCDC14ACA1CA2
SCHEMBL23428348 0.90 ALOX5 (0.42) ALOX5CDC14BCDC14ACA1CA2
SCHEMBL24518968 0.89 ALOX5 (0.44) ALOX5CDC14BCDC14AKDM4EALDH1A1
SCHEMBL24663069 0.89 ALOX5 (0.41) ALOX5CDC14BCDC14ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4245743-A1 METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION Lg Chem, Ltd. (KR) 2023-09-20 — — EP disclosed
EP-4242196-A1 METHOD FOR PREPARING DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND AND COMPOSITION Lg Chem, Ltd. (KR) 2023-09-13 — — EP disclosed
WO-2022169218-A1 METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION 주식회사 엘지화학 2022-08-11 — — WO disclosed
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, OR51E2, LOXL1 ALOX5 1073/4885CDC14B 3572/4885CDC14A 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback